The Effect of Sacubitril/Valsartan Treatment on Cardiac and Renal Functions of a Patient With Cardiorenal Syndrome Type 4 and Stage 5 CKD After More Than Three Years of Follow-Up.

Cheng, Shuiqin; Zhou, Tingting; Yu, Le; Chen, Yunmin; Zhang, Zhihong; Wang, Jinquan; Yu, Yusheng

Cheng, Shuiqin; Zhou, Tingting; Yu, Le; Chen, Yunmin; Zhang, Zhihong; Wang, Jinquan; Yu, Yusheng.

Afiliação

Cheng S; Department of Nephrology, National Clinical Research Center of Kidney Disease, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
Zhou T; Department of Nephrology, National Clinical Research Center of Kidney Disease, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
Yu L; Department of Nephrology, National Clinical Research Center of Kidney Disease, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
Chen Y; Department of Nephrology, National Clinical Research Center of Kidney Disease, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
Zhang Z; Department of Nephrology, National Clinical Research Center of Kidney Disease, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
Wang J; Department of Nephrology, National Clinical Research Center of Kidney Disease, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
Yu Y; Department of Nephrology, National Clinical Research Center of Kidney Disease, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.

Front Med (Lausanne) ; 9: 817833, 2022.

Article em En | MEDLINE | ID: mdl-35360715